Pam R. Taub, MD, FACC, FASPC
PeerWhat do we know now that could have changed the history of CETP inhibition?: genetics and biology
John Kastelein, MD, PhD
PeerStephen Nicholls, FRACP, FACC, FESC, FAHA
PeerA novel CETP inhibitor to target CV risk reduction: Where could it fit in future lipid management?
Erin D. Michos, MD, MHS, FACC, FAHA, FASE
PeerDavid Wheeler, MB, CHB, MD, FRCP
Peer